NEXIEN BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Nexien Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2014 to Q3 2024.
  • Nexien Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $10K.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $33.4K.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $174K, a 77.6% increase from 2021.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $98K, a 717% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q3 2020 $13K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q3 2017 $909K +$904K +16955% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $576K Mar 27, 2017 Jun 30, 2017 10-K 2018-09-28
Q3 2016 $5.33K +$106 +2.03% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q4 2015 $8.77K +$8.77K Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-04
Q3 2015 $5.22K +$5.22K Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-19
Q4 2014 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-04
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.